Company
Every investor coverage indicates participated in a round Citadel raised.
Investors whose own portfolio pages list Citadel, even though we haven't found any coverage of the round yet.
| Investor | Listed on |
|---|---|
| Beachhead Venture Capital | its portfolio page ↗ |
| Flying Fox Ventures | its portfolio page ↗ |
Companies Citadel acquired or merged with, per published coverage. Buying a company is not investing in one: nothing here counts in the deals column.
| Name | Role | Sources |
|---|---|---|
| Dr Miles Jakeman | CEO (former) | ARN (ARNnet) |
Stories naming Citadel. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Biotech startup Entact Bio has launched with an $81 million Series A funding its Encompass platform, which designs molecules that enhance protein function, backed by Qiming Venture Partners USA, venBio Partners and others.
Canberra security firm Archtis has added Dr Miles Jakeman, previously Citadel Group's co-founder and CEO, as a non-executive director, with the chairman praising his network and experience.